161 related articles for article (PubMed ID: 6271727)
21. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
Kays MB; White RL; Friedrich LV; Del Bene VE
Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
[TBL] [Abstract][Full Text] [Related]
22. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
[TBL] [Abstract][Full Text] [Related]
23. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
Hoellman DB; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Mar; 42(3):495-501. PubMed ID: 9517922
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
25. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
Kojo H; Shigi Y; Nishida M
J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
[TBL] [Abstract][Full Text] [Related]
26. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
28. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
Werner RG; Appel KR; Erne AM
Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
[TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
Drulak MW; Chow AW
Antimicrob Agents Chemother; 1981 Nov; 20(5):683-5. PubMed ID: 6275782
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
Vuye A
Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
[TBL] [Abstract][Full Text] [Related]
31. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Maskell JP; Nasu M; Williams JD
J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Owens WE; Finegold SM
Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
[TBL] [Abstract][Full Text] [Related]
34. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
[TBL] [Abstract][Full Text] [Related]
35. Comparative susceptibility of cefminox and cefoxitin to beta-lactamases of Bacteroides spp.
Soriano F; Edwards R; Greenwood D
J Antimicrob Chemother; 1991 Jul; 28(1):55-60. PubMed ID: 1769943
[TBL] [Abstract][Full Text] [Related]
36. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Hanslo D; King A; Shannon K; Warren C; Phillips I
J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
[No Abstract] [Full Text] [Related]
37. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Woolfrey BF; Fox JM; Quall CO
J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
[No Abstract] [Full Text] [Related]
38. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Greenfield RA; Kurzynski TA; Craig WA
Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
[TBL] [Abstract][Full Text] [Related]
39. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
Aldridge KE; Henderberg A; Sanders CV
J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Pulverer G; Peters G
Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
